© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
The story of MISSION PRED SiRNA doesn’t start overnight. Years back, scientists puzzled over how to switch off certain genes in cells to study what happens next. This curiosity gave rise to RNA interference, a tool some called revolutionary. Fire and Mello’s discovery in the late 1990s, that double-stranded RNA could silence genes, sparked a global race. Labs dusted off old cell culture flasks to explore gene silencing, and from there, commercial RNA products hit the market. MISSION PRED SiRNA joined this legacy, giving researchers a way to target genes quickly and with precision. Watching this technology reach the bench and then show up in clinical trials brought gene silencing right into clinics and universities. It’s not just chemical progress; it’s the result of decades of patience and hands-on troubleshooting.
MISSION PRED SiRNA works like a homing missile for gene silencing. By introducing specially designed, short interfering RNA molecules, this product knocks down specific genes in mammalian cells. Life scientists didn’t always have a direct path to understanding what a gene does, but now, ordering a sequence is as easy as shopping online. Sigma-Aldrich offers this catalog like a toolbox for cell biology, with sequences designed and produced to match the genetic landscape of human, mouse, and rat targets. Once delivered into cells, the siRNA binds to its target mRNA and the cell’s machinery chops it up, silencing that gene’s output. That clear-cut approach—no more making knockout mice for every question—saves both money and months.
Looking at MISSION PRED SiRNA, you get an unassuming white powder once the liquid evaporates. Dissolve it in water or buffer and you see real utility. The product usually arrives lyophilized, stable at room temperature, but best kept cold once it’s in solution. Chemically, it’s a double-stranded RNA, usually around 21 nucleotides long, with two-nucleotide 3' overhangs that help it blend in with endogenous cellular processes. This structure matters—too short, no effect; too long, the cell sounds the alarm. The chemical backbone—phosphodiester linkages—echoes nature, making it compatible with human machinery but also fairly fragile if left at room temperature too long. These physical quirks mean you need to thaw, resuspend, and freeze again with care to avoid losing money and time.
Each tube of MISSION PRED SiRNA carries not just nucleic acid but identity. The label spells out target gene symbol, ID, lot number, and amount—usually in nanomole or microgram units. Many shipments also include data sheets outlining sequence details, physical form, recommended storage temperatures, and expiration dates. That attention to labeling shows a respect for the end user. Technical datasheets go further, telling researchers how to dilute, how to deliver to cells, and estimated knockdown times. Not every company is this transparent, but these details save headaches, help with reproducibility, and make sure your grant doesn’t get wasted chasing a mislabeled product.
MISSION PRED SiRNA doesn’t grow on trees; it results from a precise process. Automated chemical synthesis linked nucleotides one by one, capped and protected, then cleaved off and purified. The process requires clean rooms, skilled staff, and exacting oversight. After that, filtration and lyophilization turn liquid to powder, extending shelf life and making transport easier. Purity matters here—a single contaminant or truncated oligo could ruin an experiment. Many vendors test for endotoxins, length, and sequence accuracy, with high-performance liquid chromatography and mass spectrometry keeping standards tight. The quality control here can mean the difference between publishing or redoing months of work.
Early siRNA developers faced a challenge: RNA degraded quickly in cells, and sometimes triggered unwanted immune responses. MISSION PRED SiRNA took this lesson to heart. Many formulations include chemical modifications like 2’-O-methylation or phosphorothioate linkages that block nucleases from chewing up the strands. Fluorescent labels sometimes help researchers track delivery into cells, while locked nucleic acids can boost stability. These tweaks offer a major benefit: extended silencing, reduced toxicity, and better consistency. Chemistry isn’t just for textbooks here—it’s literally the difference between fruitless cell culture and clear, reliable gene knockdown.
Not every scientist calls it MISSION PRED SiRNA. Depending on the catalog or literature, names range from “predesigned siRNA” to “custom gene silencing oligos.” Commercial sources may tag products as “Sigma MISSION siRNA,” “Sigma-Aldrich PRED siRNA,” or simply “siRNA duplexes.” This variety isn’t just marketing; it reflects attempts to capture the same process under different research umbrellas, each tailored for niche applications like pooled screening, single gene studies, or high-throughput projects.
Lab safety gets real with RNA. SiRNA itself poses low hazard to humans, but the reagents needed for delivery—like cationic lipids or electroporation buffers—bring risks. Gloves, lab coats, and eye protection become routine. And cross-contamination hovers as a real threat, since traces of nucleases on a pipette tip can wreck experiments. Many labs keep special, nuclease-free water, tips, and tubes just for RNA work. Waste disposal takes extra attention—no one wants a gene silencer loose in the ecosystem. Adhering to operational standards allows for both cleaner results and fewer headaches from failed runs or unexpected cell death.
MISSION PRED SiRNA transformed how biologists approach gene function. In cancer labs, scientists flip the switch on oncogenes and observe what happens to cell growth. Immunologists slow down inflammatory mediators and watch immune responses. I’ve seen neuroscience groups use it to untangle complex signaling pathways in brain cells. Pharma companies run high-throughput screens, silencing hundreds of genes to spot new drug targets. A quick transfection and in less than 48 hours, the effect emerges. These applications speed up the research cycle, which encourages bolder experiments and more creative projects in areas ranging from rare disease models to infectious disease screens.
Research on MISSION PRED SiRNA hasn’t slowed down since its launch. New manufacturing protocols focus on higher purity and longer shelf life. Ongoing work aims to reduce off-target effects by refining sequence algorithms. Collaborative projects between industry and academia chase new delivery systems, hoping to bring gene silencing to tissues that resist standard transfection. In my experience, R&D teams treasure feedback—users’ complaints about transfection failures or unexpected silencing spark innovation, leading to more robust kits and better user guides. Grants from public agencies still pour into labs promising new RNAi tools, ensuring that every year brings an updated product or a cleaner workflow.
Toxicity once threatened the promise of RNAi, as early siRNAs sometimes sent cells into panic, triggering immune or stress responses. MISSION PRED SiRNA integrates what toxicology teams have learned. Designed sequences aim to avoid immune motifs, and new modifications reduce recognition by sensors like toll-like receptors. Plenty of published literature now guides users on monitoring for signs of cell stress, and most companies run cell viability assays as part of their QC. I’ve seen researchers run their own side-by-side tests to check for toxicity in sensitive primary cells. While unexpected toxicity can still crop up, most modern siRNA duplexes avoid the pitfalls that plagued early adopters.
The future of MISSION PRED SiRNA stretches beyond the lab dish. Clinical trials already test RNAi in rare and common diseases alike, including neurodegenerative disorders and cancer. Scientists now look for ways to deliver siRNA to hard-to-reach tissues with nanoparticles, exosomes, or viral vectors. AI-driven sequence design promises even lower off-target effects. More affordable and robust products may soon let smaller labs perform genome-wide screens without breaking the bank. If the past twenty years are any guide, the next innovations in siRNA will come not just from chemical tweaks or new delivery gadgets, but from researchers combining what’s available to ask—and answer—even bigger questions about how genes shape life.
MISSION PRED SiRNA isn’t just jargon from the world of biotechnology. It’s a tool that scientists count on for silencing genes in mammalian cells. Researchers use it to turn off specific genes and see what happens next. This isn’t just abstract curiosity. Scientists rely on this tool to figure out how diseases like cancer and diabetes develop. If a certain gene causes healthy cells to go haywire, PRED SiRNA allows teams to stop that gene and watch how the cells respond.
Cancer labs and pharmaceutical companies need to know which genes push cells to divide uncontrollably. In my own work supporting medical research, I’ve seen teams use MISSION PRED SiRNA libraries to pick apart huge lists of possible gene suspects. Instead of guessing, researchers can pinpoint the genes responsible for making cells grow, survive, or even resist treatment. The ability to “silence” a gene and watch the fallout speeds up cancer research by years. For many patients, that speed really matters.
The reach goes further than cancer labs. Scientists study rare genetic diseases the same way. A team struggling to understand a neurological disorder can use PRED SiRNA to dampen specific genes and catch the subtle differences in cell behavior. In virology, labs can test which human genes viruses rely on, which helps design better antivirals. Once researchers know the weakest links, they can design drugs targeting those connections. Clinicians may not work with these molecules directly, but many treatments on the market owe their early origins to this kind of research.
MISSION PRED SiRNA stands out because of its reliability. Hundreds of citations back its use. Sigma-Aldrich, the company behind the product, published technical data and user guides covering off-target risks, delivery approaches, and controls. Respect comes from consistency. My own colleagues complain when a reagent gives unpredictable results; lost time shapes research careers. When a tool like PRED SiRNA delivers consistent performance, it fuels confidence in the data. That trust means discoveries are more likely to hold up once they leave the bench.
Scientists working in university or hospital settings always talk about budgets. Even as PRED SiRNA gives big returns, costs can strain smaller labs. Some researchers pool funds or share libraries to run experiments on a shoestring. Efficient delivery systems also matter. Getting SiRNA into cells without damaging them isn’t straightforward. Technology has improved, but no system is perfect. Off-target effects pose another risk: sometimes a SiRNA sequence turns off genes that researchers didn’t mean to, leading to wrong conclusions. Scrupulous experiment planning and the use of control reagents keep accidental errors in check.
As gene-editing technologies expand, RNA interference will remain vital in genetics labs. Whether it’s for finding new drug targets, clarifying gene roles, or discovering what truly causes diseases, this tool keeps making waves. Robust scientific methods, good data recording, and honest result reporting shape reliable breakthroughs. Science advances with reliable tools and a community willing to adapt and learn. That’s why PRED SiRNA continues to earn its place on the lab bench.
Picking the best siRNA sequence feels a bit like panning for gold—you sift through a lot of options before finding a winner that knocks the gene expression down, without giving you endless off-target headaches. From my years shuffling between the bench and the computer, I’ve seen the difference between a well-chosen sequence and a half-baked guess. The margin between clean knockdown data and noise boils down to the right design and validation.
Let’s keep things simple. For MISSION PRED siRNA selection, the toughest part comes down to ensuring specificity along with strong silencing. Not every sequence is created equal. Algorithms and databases crank out plenty of potential siRNA targets, but not every result survives real-world testing. The sweet spot usually pops up around position 100-200 nucleotides after the start codon, steering clear of untranslated regions because those spots trip up degradation. Select regions where the mRNA stands out from closely related family members, or you might silence a bunch of genes you didn’t mean to touch.
Bullseye design often skips runs of four or more Gs or Cs, avoiding those sequence stretches that fold up into secondary structures. A healthy dose of A and U nucleotides at positions 1 to 7 of the antisense strand gives you better silencing, based on data that’s held up across labs. On top of that, standard GC content between 30-50% cuts the weeds—too much or too little and you risk losing the plot altogether.
Some tools and platforms claim they can handle the job for you. From my last projects, automated systems often spit out plenty of options, but their suggestions work best as a starting line. Always throw your intended siRNA sequence into BLAST or a similar alignment tool. Cross-check that your target doesn’t overlap with unrelated genes. In my lab, skipping this step set us back weeks after seeing effects in cells that had nothing to do with our target.
Now, off-target effects keep burning people, especially when a sequence gets picked straight off a website. Sigma’s MISSION siRNAs get filtered through multiple rounds of prediction and pre-validation, which weeds out a lot of duds before you even pipette a drop. Still, even commercial options don’t guarantee perfection. Pooling three to four unique, non-overlapping siRNAs aimed at the same gene flattens the odds of weird side effects. If you hit the same gene with multiple sequences and the only thing in common is your target, you can trust your knockdown claims.
Even after ordering, you need to double-check everything. Run your knockdown in a qRT-PCR or western blot, see the drop in expression, and make sure your downstream readouts line up with the literature. Build in proper negative controls using scrambled siRNA. This step often spares me the embarrassment of writing up what turns out to be an artifact.
Never shortcut the process. Building a reputation for good science means going beyond using the shortest path between theory and experiment. As sequencing tech gets cheaper and CRISPR rises, siRNA work still drives many functional studies, so every choice matters. My advice: start with the basics, trust the data over anyone’s promise, and build a playbook you can rely on, project after project.
A lot of great research depends on tiny strands like MISSION PRED SiRNA, but keeping those molecules reliable day-in, day-out takes more than tossing tubes in any cold box. Small interfering RNAs work like precision tools in gene silencing—misplace one tool or let it blunt, and hours of planning can head straight for the trash. One lesson learned early in lab life: treat reagents like gold if you want results to match the effort spent.
I’ve stood with frustrated colleagues who learned the hard way about freezer drift. Most researchers store MISSION PRED SiRNA at -20°C for short-term, or even lower at -80°C if the plan involves using the same lot for months. It’s not fussy, but it won’t last on a warm benchtop. Degradation speeds up if samples thaw and re-freeze, which a stack of published studies suggest can break down the two-strand structure. Scientists run negative controls for a reason—one bout of RNase contamination or a day in the wrong freezer, and signals vanish from PCR readouts.
Water in the wrong place ruins a whole batch. Lyophilized—meaning dried out—siRNA proves the most stable. I’ve seen experienced techs dry everything down before long-term storage, sealing tubes tight and adding desiccant. Reconstitute only right before use with sterilized, RNase-free water. Lab lore says moisture lets RNases in, and those enzymes chew up RNA fast. Even a fingerprint on the rim of a microtube cap can be a risk, so gloves and clean pipette tips are a must.
People sometimes ask if siRNA lasts forever at the right cold temperature. Nothing does, at least not perfectly. Data from real-world labs and Sigma-Aldrich’s own documentation agree: lyophilized MISSION PRED siRNA stays reliable for 6 months or more at -20°C. Dissolved siRNA won’t keep as long—two tips from local postdocs: finish up dissolved aliquots in a week, and never dip into the original stock twice. Aliquot before opening, mark freezer boxes, and keep detailed logs to track freeze-thaw cycles.
Mission PRED siRNA ships without stabilizing proteins or colored dyes for a reason—those extras often change the way enzymes interact. Handling should avoid buffers with divalent cations or complexing agents that affect reactivity. The formula may look simple but, even after years in the lab, every misstep—left out too long, shaking too hard, mixing with tap water—shows up in experimental noise or fading knockdown.
New students sometimes see the container, read the label, then leave it on the bench—tiny things, big waste. Experienced teams keep siRNA in the cold until all steps are lined up. Every use starts with checking expiration dates and inspecting for visible powder or residue at the bottom of the tube. Stocks stay labeled by date, not just product name.
Some labs now run periodic stability checks—testing a small sample at intervals with quantitative PCR or gel shifts. Tracking helps catch problems early. Adding a simple sign-out sheet near the freezer serves as a reminder: everyone who grabs a tube notes down the time, which cuts down blame if problems pop up later. If storage conditions get overlooked, not only do budgets take a hit, but published data can grow shaky. In the hunt for clear gene knockdown, paying attention to basics keeps projects—and reputations—safe.
People walk into a lab and hope for clean results. But SiRNA work always calls for careful steps. MISSION PRED SiRNA relies on solid technique, not just following a recipe but understanding how these small interfering RNAs interact with cells. From my own work with transfection protocols, small issues in reagent ratios or culture conditions lead to headaches, failed knockdowns, or even dead cells. That’s why every developer or biologist must treat every detail, no matter how boring it looks, as crucial to good science.
Before jumping in, take care of the basics. Start with healthy cells, usually at 50-70% confluency. Too crowded or starving cultures don’t rebound well after reagent exposure. Use clean reagents and pipettes. Contamination messes up readouts and wastes costly SiRNA. Wear gloves. Even small mistakes show in gene expression data.
I always check cell density under the microscope and keep a running log of plate batches. This habit helped me spot off days or reagent variability—stuff easy to overlook if you trust everything will behave exactly as advertised.
Add MISSION PRED SiRNA to serum-free medium, usually Opti-MEM or similar. Don’t skimp on mixing—gently flick the tube, aiming for full dispersal, not bubbles. Next, dilute your transfection reagent separately (many use Lipofectamine, but careful, some cell lines hate certain formulations).
Let the SiRNA and transfection reagent sit apart for a few minutes, five at minimum. Combine them. Let the mixture stand for 15-20 minutes; this forms complexes that cells actually take up. Patience here pays off—too short, and knockdown fails; too long, and complexes fall apart.
Add these complexes dropwise to your cells, swirling if you’ve used larger wells. Never rush the mixing. Plate movement helps uniform growth after the shock. Some labs, including mine, swap out the transfection medium with fresh, serum-containing medium after four to six hours. Cells get stressed if you leave them hungry too long.
Concentration really makes or breaks your outcome. Many start with 10 to 50 nM SiRNA, but you need to try a range to avoid off-target effects or cell toxicity. For transfection reagent volumes, follow the manufacturer’s directions at first, then fine-tune. I usually do a pilot with a control SiRNA and measure viability and knockdown at twenty-four and forty-eight hours.
Don’t trust single readouts. Combine qPCR, Western blot, and viability assays for a fuller picture. Once I only checked mRNA, but protein stayed. That taught me that half-finished knockdown stories hide in the data. Trusting only kit protocols without internal controls is risky. Troubleshooting eats up weeks if you try to wing optimization.
Transfection reagents carry some risks. Read the MSDS and avoid direct contact. MISSION PRED SiRNA isn’t cheap—store it at -20°C, and avoid repeated freeze-thaw cycles. Quality drops every time SiRNA thaws, so aliquot if you use small volumes.
Cells respond differently to each lot of SiRNA, so document everything: passage numbers, reagent lot, even who plated the cells. This level of record-keeping isn’t just bureaucracy—it saves projects when results swing for no clear reason.
It’s easy to see protocols as a hoop to jump through. In practice, careful prep and open troubleshooting turn MISSION PRED SiRNA transfection from a source of frustration into a reliable research tool. The extra time at the start pays off down the road in reproducible results and cleaner science. Not all protocols fit every cell line, but a measured, attentive approach always keeps experiments moving forward, even as new SiRNA tools keep arriving on the market.
Anybody who’s worked in a lab knows the frustration of getting inconsistent results. Even the best siRNA reagents can’t fix sloppy experimental design. Good science relies on controls to separate background noise from true effects. MISSION PRED siRNA, like any gene silencing tool, isn’t magic — it gets its strength when used in a well-controlled system.
Smart scientists set up their siRNA experiments with both non-targeting and positive controls. Non-targeting controls use sequences that don’t match any genes in the species you’re working with. They help reveal changes in gene expression or cell behavior that come from the transfection process, rather than gene knockdown. For example, transfection itself might spur a cell’s stress response. Skipping non-targeting controls means risking false conclusions about what the siRNA has actually done.
Positive controls target genes with well-known and easily measured effects. GAPDH or Lamin A/C get used a lot because researchers can spot knockdown quickly with simple assays. If a positive control works, that tells you the delivery method succeeded — and so did the reagent quality. If it fails, the experiment needs to be re-checked, whether for siRNA degradation, issues with transfection reagents, or cell health.
Most researchers worry about off-target effects. Even well-designed siRNAs may silence unintended genes. Including more than one siRNA targeting different sequences of the same gene — and showing similar results — gives confidence in the data. This approach builds trust because consistent outcomes across different targeting points rarely happen by accident.
A long tenure in academic labs taught me never to skip a BLAST search on any siRNA sequence. Confirm nothing except the gene of interest is being hit. Several published papers, including in Nature Methods, point to off-target gene silencing as a leading source of reproducibility issues. By running a BLAST, scientists avoid surprises and keep their results credible.
Verification doesn’t stop with siRNA controls. Every gene expression study needs a reliable housekeeping gene as a “loading control.” These are genes expected to maintain steady expression, such as ACTB or HPRT1. Keeping one eye on these standards makes sure that changes in mRNA or protein aren’t due to general cell damage or uneven sample amounts. For western blots, always compare band intensity against the reference.
Even with all technical controls, mistakes happen. I’ve seen failed experiments turn out to be mix-ups in tube labeling or pipetting. Detailed lab notes trace every sample through the workflow and cut down on confusion. Labels, checklists, and routine inventory spot issues before they ruin experiments.
Missed knockdown or unexpected results mean going back to basics. Double-check siRNA and control integrity using gel electrophoresis. Confirm transfection efficiency with a fluorescent marker or by following up with a qPCR on a positive control. Adjust the amount of reagent, or give cells more time — every cell line responds differently.
Colleagues, reviewers, and grant agencies want to trust the data you generate. Consistent use of controls with MISSION PRED siRNA gives your findings strength. No technology replaces thoughtful planning and a habit of looking critically at your own work. In my experience, the labs that win the most respect in the field pay close attention to these details. Solid controls aren’t just a technicality. They set your science apart.
| Names | |
| Preferred IUPAC name | N-{2-hydroxyethyl}-2-{[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}-N-methylacetamide |
| Other names |
MISSION Predesigned siRNA MISSION Predesigned Small Interfering RNA Predesigned siRNA |
| Pronunciation | /ˈmɪʃ.ən prɛd ˌsaɪˌɑrˌɛnˈeɪ/ |
| Identifiers | |
| CAS Number | 1160272-12-9 |
| Beilstein Reference | 2142222 |
| ChEBI | CHEBI:73303 |
| ChEMBL | CHEMBL1743081 |
| ChemSpider | 4700876 |
| DrugBank | DB00118 |
| ECHA InfoCard | echa-info-card::100.259.058 |
| Gmelin Reference | GMELIN:104579 |
| KEGG | KEGG |
| MeSH | RNA, Small Interfering |
| PubChem CID | 139105256 |
| RTECS number | GF1050000 |
| UNII | 67VLW6F13F |
| UN number | UN1993 |
| CompTox Dashboard (EPA) | DTXSID20229798 |
| Properties | |
| Chemical formula | C254H404N72O77P19 |
| Molar mass | Molecular Weight: varies, typically 13,000–14,000 g/mol |
| Appearance | Off-white to beige solid |
| Odor | Odorless |
| Density | 0.86 g/cm³ |
| Solubility in water | RNase-free water |
| log P | 4.15 |
| Acidity (pKa) | 6.0 |
| Basicity (pKb) | 7.0 |
| Refractive index (nD) | 1.335 |
| Viscosity | 0.8 cP |
| Dipole moment | 7.0328 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 247.91 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | No ATC code. |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory tract irritation. |
| GHS labelling | GHS07: Exclamation Mark |
| Pictograms | Eco-friendly, Fast Delivery, Strict QC |
| Signal word | Warning |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P305+P351+P338, P501 |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 0, Instability: 0, Special: - |
| Flash point | > 100 °C |
| NIOSH | NIOSH: Not listed |
| PEL (Permissible) | 0.1 mg/m3 |
| REL (Recommended) | 1.00 µM |
| Related compounds | |
| Related compounds |
MISSION esiRNA MISSION shRNA MISSION microRNA Mimics MISSION Synthetic miRNA Inhibitors MISSION CONTROL siRNA MISSION CRISPR Products |
